STOCK TITAN

Planned 29,700-share sale of issuer (CRSP) common stock disclosed in filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Raju Prasad filed a notice of proposed sale of the issuer’s common stock under Rule 144. The planned transaction covers 29,700 common shares, to be sold through Morgan Stanley Smith Barney LLC with an aggregate market value of $1,786,635.87, based on information in the filing. The shares relate to a stock option exercise on 01/06/2026, paid in cash the same day, and are expected to be sold around 01/06/2026 on the NASDAQ market, where 95,300,233 shares of this class are outstanding.

The filing also reports that over the prior three months, Prasad sold 10,000 common shares on 12/22/2025 for $559,548.00. By signing, the seller represents they are not aware of undisclosed material adverse information about the issuer’s current or prospective operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many shares are being registered for sale in this CRSP Form 144?

The notice covers a proposed sale of 29,700 shares of the issuer’s common stock, with an aggregate market value of $1,786,635.87 as indicated in the filing.

How were the 29,700 shares in the CRSP Form 144 acquired?

The 29,700 common shares were acquired on 01/06/2026 through a stock option exercise from the issuer, with the purchase price paid in cash on the same date.

Which broker and exchange are involved in this CRSP Form 144 sale?

The planned sale is through Morgan Stanley Smith Barney LLC Executive Financial Services, and the shares are expected to be sold on the NASDAQ exchange.

How many shares of this class are currently outstanding for the issuer in the CRSP filing?

The filing states that there are 95,300,233 shares of the relevant class of common stock outstanding.

What prior share sales by Raju Prasad are disclosed in this CRSP Form 144?

Over the past three months, the filing reports that Raju Prasad sold 10,000 common shares on 12/22/2025 for $559,548.00 in gross proceeds.

What representation does the seller make in signing this CRSP Form 144?

By signing, the seller represents that they do not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.
Crispr Therapeut

NASDAQ:CRSP

CRSP Rankings

CRSP Latest News

CRSP Latest SEC Filings

CRSP Stock Data

5.10B
93.75M
1.64%
80.94%
24.27%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
Switzerland
ZUG